FDA Approved: BOSENTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for bosentan submitted by Lupin Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis with Digital Ulcers

Drugs mentioned

• Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)